Dose reduction and discontinuation of conventional synthetic disease‐modifying anti‐rheumatic drugs for people with rheumatoid arthritis or psoriatic arthritis in remission or low disease activity

Written By Krista Verlis

Pisaniello HL, Whittle SL, Johnston RV, et al. Dose reduction and discontinuation of conventional synthetic disease-modifying anti-rheumatic drugs (DMARDs) for people with rheumatoid arthritis or psoriatic arthritis in remission or low disease activity. Cochrane Database Syst Rev. 2025;9:CD015900. Published 2025 Sep 30. doi:10.1002/14651858.CD015900

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015900/full

Krista Verlis
Previous

Less is more for patients, practitioners, public and planet: a taxonomy for the harms of too much medicine
Next

Influence of Anecdotes of IVF Success on Treatment Decision Making: An Online Randomized Controlled Trial